Skip to main content
SpringerLink
Log in

Sentinel Node Biopsy and Nodal Staging

  • Chapter
  • First Online:
Breast Cancer, a Heterogeneous Disease Entity

Abstract

The presence or absence of lymph node metastases has been claimed as the single most important prognostic factor in breast cancer, what may not hold true for the smallest tumors detected through screening, which are often node-negative. Traditionally, this was assessed by the histological examination of the nodal content of the axilla removed during axillary lymph node dissection (ALND). Sentinel lymph node (SLN) biopsy (SLNB), a low morbidity surgical pathological staging procedure has now widely replaced ALND, especially in the earliest stages of the disease, where ALND often yielded a negative nodal status and therefore proved to be an unnecessary overtreatment. SLNB too, often yields negative results, and raises the question whether or not surgical nodal staging is required at all for small screen detected carcinomas. Although it is generally common to perform a completion axillary dissection when an SLN is involved by metastatic disease, further lymph nodes are only seldom affected by the disease. Therefore, the idea of omitting further axillary treatment after the finding of a positive SLN in these patients with generally favorable outcome needs to be seriously considered in order to reduce their morbidity and overtreatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abdessalam SF, Zervos EE, Prasad M et al (2001) Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182:316–320

    Article  PubMed  CAS  Google Scholar 

  • Ahlgren J, Holmberg L, Bergh J et al (2002) Five-node biopsy of the axilla: an alternative to axillary dissection of levels I--II in operable breast cancer. Eur J Surg Oncol 28:97–102

    Article  PubMed  CAS  Google Scholar 

  • Anan K, Mitsuyama S, Kuga H et al (2006) Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection. Surgery 139:630–632

    Article  Google Scholar 

  • Ansari B, Ogston SA, Purdie CA et al (2008) Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg 95:547–554

    Article  PubMed  CAS  Google Scholar 

  • Arnes JB, Collett K, Akslen LA (2008) Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. Histopathology 52:370–380

    Article  PubMed  CAS  Google Scholar 

  • Banerjee S, Reis-Filho JS, Ashley S et al (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 59:729–735

    Article  PubMed  CAS  Google Scholar 

  • Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119

    Article  PubMed  Google Scholar 

  • Bauerfeind IG, Kahlert S, Himsl I et al (2007) The risk of non-sentinel metastases in primary breast cancer. Anticancer Res 27:1929–1932

    PubMed  Google Scholar 

  • Bergkvist L, Frisell J, Liljegren G et al (2001) Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 88:1644–1648

    Article  PubMed  CAS  Google Scholar 

  • Bevilacqua JL, Kattan MW, Fey JV et al (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25:3670–3679

    Article  PubMed  Google Scholar 

  • Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946–2953

    Article  PubMed  Google Scholar 

  • Blamey RW, Ellis IO, Pinder SE et al (2007) Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999. Eur J Cancer 43:1548–1555

    Article  PubMed  CAS  Google Scholar 

  • Bleiweiss IJ, Nagi CS, Jaffer S (2006) Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24:2013–2018

    Article  PubMed  Google Scholar 

  • Blumencranz P, Whitworth PW, Deck K et al (2007) Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 194:426–432

    Article  PubMed  Google Scholar 

  • Bolster MJ, Peer PG, Bult P et al (2007) Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol 14:181–189

    Article  PubMed  Google Scholar 

  • Boughey JC, Khakpour N, Meric-Bernstam F et al (2006) Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107:1440–1447

    Article  PubMed  Google Scholar 

  • Broekhuizen LN, Wijsman JH, Peterse JL et al (2006) The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. World J Surg Oncol 32:502–506

    CAS  Google Scholar 

  • Caliskan M, Gatti G, Sosnovskikh I et al (2008) Paget’s disease of the breast: the experience of the European institute of oncology and review of the literature. Breast Cancer Res Treat 112:513–521

    Article  PubMed  Google Scholar 

  • Carter BA, Page DL (2006) Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact. J Clin Oncol 24:1978–1979

    Article  PubMed  Google Scholar 

  • Chagpar AB, Scoggins CR, Martin RC II et al (2006) Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg 192:882–887

    Article  PubMed  Google Scholar 

  • Chagpar AB, Scoggins CR, Martin RC II et al (2007) Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 14:670–677

    Article  PubMed  Google Scholar 

  • Changsri C, Prakash S, Sandweiss L et al (2004) Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J 10:392–397

    Article  PubMed  Google Scholar 

  • Chivukula M, Haynik DM, Brufsky A et al (2008) Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 32:1721–1726

    Article  PubMed  Google Scholar 

  • Cho J, Han W, Lee JW et al (2008) A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol 15:2278–2286

    Article  PubMed  Google Scholar 

  • Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106

    PubMed  CAS  Google Scholar 

  • Cody HS III (2003) Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol 10:1131–1132

    Article  PubMed  Google Scholar 

  • Cody HS III, van Zee KJ (2008) Predicting nonsentinel node metastasis in sentinel node-positive breast cancer: what have we learned, can we do better, and do we need to? Ann Surg Oncol 15:2998–3002

    Article  PubMed  Google Scholar 

  • Colleoni M, Rotmensz N, Peruzzotti G et al (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379–1389

    Article  PubMed  Google Scholar 

  • Colpaert C, Vermeulen P, Jeuris W et al (2001) Early distant relapse in “node-negative” breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 193:442–449

    Article  PubMed  CAS  Google Scholar 

  • Conn CA, McMasters KM, Edwards MJ et al (2005) Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J 11:229–230

    Article  Google Scholar 

  • Coufal O, Pavlík T, Fabian P et al (2009) Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a czech population? Pathol Oncol Res May 15. (Epub ahead of print)

    Google Scholar 

  • Cox CE, Nguyen K, Gray RJ et al (2001) Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67:513–521

    PubMed  CAS  Google Scholar 

  • Crippa F, Gerali A, Alessi A et al (2004) FDG-PET for axillary lymph node staging in primary breast cancer. Eur J Nucl Med Mol Imaging 31(Suppl 1):S97–S102

    Article  PubMed  Google Scholar 

  • Cserni G (2000) Axillary staging of breast cancer and the sentinel node. J Clin Pathol 53:733–741

    Article  PubMed  CAS  Google Scholar 

  • Cserni G (2002) Sentinel node biopsy as a tool for the staging of “ductal carcinoma in situ” in patients with breast carcinoma. Surg Today 32:99–103

    Article  PubMed  Google Scholar 

  • Cserni G (2006) Further axillary metastases associated with isolated tumor cells in sentinel lymph nodes of breast cancer patients. Ann Surg 243:287

    Article  PubMed  Google Scholar 

  • Cserni G (2007a) What is a positive sentinel lymph node in breast cancer patients? A practical approach. Breast 16:152–160

    Article  Google Scholar 

  • Cserni G (2007b) Pathological evaluation of sentinel lymph nodes. Surg Oncol Clin North Am 16:17–34

    Article  Google Scholar 

  • Cserni G (2008a) Sentinel nodes, micrometastases and isolated tumor cells. In: Walker RA, Thompson AM (eds). Prognostic and predictive factors in breast cancer, 2nd edn. Informa Healthcare, London, pp 68–87

    Google Scholar 

  • Cserni G (2008b) Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol 61:1333–1335

    Article  Google Scholar 

  • Cserni G, Amendoeira I, Apostolikas N et al (2003) Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654–1667

    Article  PubMed  CAS  Google Scholar 

  • Cserni G, Amendoeira I, Apostolikas N et al (2004a) Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57:695–701

    Article  CAS  Google Scholar 

  • Cserni G, Burzykowski T, Vinh-Hung V et al (2004b) Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 34:519–524

    Article  Google Scholar 

  • Cserni G, Boross G, Maráz R et al (2006) Sentinel lymph node biopsy for in situ carcinoma of the breast. Experience at the Bács-Kiskun County Hospital and review of the literature. (In Hungarian) Magy Seb 59:164–172

    PubMed  Google Scholar 

  • Cserni G, Bianchi S, Vezzosi V et al (2007a) Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study. Pathol Oncol Res 13:5–14

    Article  Google Scholar 

  • Cserni G, Bianchi S, Vezzosi V et al (2007b) Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis. Eur J Cancer 43:1407–1414

    Article  Google Scholar 

  • Cserni G, Bianchi S, Vezzosi V et al (2007c) Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients. Am J Surg 194:288–293

    Article  Google Scholar 

  • Cserni G, Bori R, Sejben I et al (2009) Analysis of predictive tools for further axillary involvement in patients with sentinel lymph node positive small (≤15 mm) invasive breast cancer. Orv Hetil 150:2182–2188

    Article  PubMed  Google Scholar 

  • Cutuli B, De Lafontan B, Vitali E et al (2009) Breast conserving treatment (BCT) for stage I–II breast cancer in elderly women: analysis of 927 cases. Crit Rev Oncol Hematol 71:79–88

    Article  PubMed  Google Scholar 

  • D’Eredita’ G, Giardina C, Martellotta M et al (2001) Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 37:591–596

    Article  PubMed  Google Scholar 

  • Dawson SJ, Duffy SW, Blows FM et al (2009) Molecular characteristics of screen-detected vs. symptomatic breast cancers and their impact on survival. Br J Cancer 101:1338–1344

    Article  PubMed  CAS  Google Scholar 

  • de Boer M, van Deurzen CH, van Dijck JA et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653–663

    Article  PubMed  Google Scholar 

  • De Mascarel I, MacGrogan G, Debled M et al (2008) Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful? Cancer 112:1672–1678

    Article  Google Scholar 

  • Degnim AC, Griffith KA, Sabel MS et al (2003) Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98:2307–2315

    Article  PubMed  Google Scholar 

  • Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550

    Article  PubMed  Google Scholar 

  • Deurloo EE, Tanis PJ, Gilhuijs KG et al (2003) Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39:1068–1073

    Article  PubMed  CAS  Google Scholar 

  • Di Tommaso L, Arizzi C, Rahal D et al (2006) Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status. Ann Surg 243:706–707

    Article  PubMed  Google Scholar 

  • Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? Am J Roentgenol 173:1303–1313

    CAS  Google Scholar 

  • Diaz NM, Cox CE, Ebert M et al (2004) Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol 28:1641–1645

    Article  PubMed  Google Scholar 

  • Dillon MF, Hill AD, Quinn CM et al (2004) Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer. J Med Screen 11:130–134

    Article  PubMed  CAS  Google Scholar 

  • Dowlatshahi K, Fan M, Snider HC et al (1997) Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–1197

    Article  PubMed  CAS  Google Scholar 

  • Doyle B, Al-Mudhaffer M, Kennedy MM et al (2009) Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol 62:534–538

    Article  PubMed  CAS  Google Scholar 

  • Driouch K, Landemaine T, Sin S et al (2007) Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis. Clin Exp Metastasis 24:575–585

    Article  PubMed  CAS  Google Scholar 

  • Edge SB, Byrd DR, Compton CC et al (eds) (2009) AJCC cancer staging handbook: from the AJCC Cancer Staging Manual. Springer, New York

    Google Scholar 

  • Estourgie SH, Nieweg OE, Valdés Olmos RA et al (2003) Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol 29:336–340

    Article  PubMed  CAS  Google Scholar 

  • Farshid G, Pradhan M, Kollias J et al (2004) A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast 13:494–501

    Article  PubMed  Google Scholar 

  • Fougo JL, Afonso M, Senhorães Senra F et al (2009) Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors? Clin Transl Oncol 11:165–171

    Article  PubMed  CAS  Google Scholar 

  • Foulkes WD, Grainge MJ, Rakha EA et al (2009) Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Breast Cancer Res Treat 117:199–204

    Article  PubMed  Google Scholar 

  • Galimberti V (2006) International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol 24:210–211

    Article  PubMed  Google Scholar 

  • Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398

    Article  PubMed  CAS  Google Scholar 

  • Giuliano AE, Dale PS, Turner RR et al (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394–401

    Article  PubMed  CAS  Google Scholar 

  • Gould VE, Bloom KJ, Franke WW et al (1995) Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch 425:617–629

    Article  PubMed  CAS  Google Scholar 

  • Goyal A, Douglas-Jones A et al (2004) Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 40:1731–1737

    Article  PubMed  CAS  Google Scholar 

  • Goyal A, Newcombe RG, Chhabra A et al (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203–208

    Article  PubMed  Google Scholar 

  • Greco M, Crippa F, Agresti R et al (2001) Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 93:630–635

    Article  PubMed  CAS  Google Scholar 

  • Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC Cancer Staging Handbook—TNM classification of malignant tumors, 6th edn. Springer Verlag, New York

    Google Scholar 

  • Grube BJ, Giuliano AE (2001) Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20:230–237

    Article  PubMed  CAS  Google Scholar 

  • Haigh PI, Hansen NM, Qi K et al (2000) Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7:21–27

    Article  PubMed  CAS  Google Scholar 

  • Haybittle JL, Blamey RW, Elston CW et al (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361–366

    Article  PubMed  CAS  Google Scholar 

  • Holloway C (2000) Surgery for ductal carcinoma in situ. Curr Probl Cancer 24:141–162

    Article  PubMed  CAS  Google Scholar 

  • Houvenaeghel G, Nos C, Giard S et al (2008) A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 35(7):690–695

    Article  PubMed  Google Scholar 

  • Hsu GC, Ku CH, Yu JC et al (2006) Application of intraoperative ultrasound to nonsentinel node assessment in primary breast cancer. Clin Cancer Res 12:3746–3753

    Article  PubMed  Google Scholar 

  • https://www.adjuvantonline.com/breastnew.jsp

  • Hwang RF, Krishnamurthy S, Hunt KK et al (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254

    Article  PubMed  Google Scholar 

  • Intra M, Veronesi P, Mazzarol G et al (2003a) Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138:309–313

    Article  Google Scholar 

  • Intra M, Zurrida S, Maffini F et al (2003b) Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 10:1160–1165

    Article  Google Scholar 

  • Intra M, Veronesi P, Gentilini OD et al (2007) Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol 95:175–179

    Article  PubMed  Google Scholar 

  • Intra M, Rotmensz N, Veronesi P et al (2008) Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 247:315–319

    Article  PubMed  Google Scholar 

  • Jaffer S, Lin R, Bleiweiss IJ, Nagi C (2008) Intraductal carcinoma arising in intraductal papilloma in an axillary lymph node. Arch Pathol Lab Med 132:1940–1942

    PubMed  Google Scholar 

  • Jinno H, Sakata M, Asaga S et al (2008) Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Breast J 14:551–555

    Article  PubMed  Google Scholar 

  • Kattan MW, Giri D, Panageas KS et al (2004) A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer 101:2509–2515

    Article  PubMed  Google Scholar 

  • Katz A, Smith BL, Golshan M et al (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093–2098

    Article  PubMed  Google Scholar 

  • Kelly TA, Kim JA, Patrick R et al (2003) Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 186:368–370

    Article  PubMed  Google Scholar 

  • Klauber-DeMore N, Tan LK, Liberman L et al (2000) Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7:636–642

    Article  PubMed  CAS  Google Scholar 

  • Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66

    Article  PubMed  Google Scholar 

  • Krag DN, Weaver DL, Alex JC et al (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–240

    Article  PubMed  CAS  Google Scholar 

  • Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888

    Article  PubMed  CAS  Google Scholar 

  • Leidenius MH, Ortiz A, Rönkä RH et al (2002) Case report: complete lymphatic staging in breast cancer by lymphoscintigraphy and sentinel node biopsy. Int Surg 87:160–163

    PubMed  Google Scholar 

  • Leidenius MH, Vironen JH, Riihelä MS et al (2005) The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 31:13–18

    Article  PubMed  CAS  Google Scholar 

  • Liberman L, Vuolo M, Dershaw DD et al (1999) Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. Am J Roentgenol 172:677–681

    CAS  Google Scholar 

  • Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3563

    Article  PubMed  Google Scholar 

  • Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720

    Article  PubMed  Google Scholar 

  • Macmillan RD, Barbera D, Hadjiminas DJ et al (2001) Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer 37:1076–1080

    Article  PubMed  CAS  Google Scholar 

  • Maiorano E, Mazzarol GM, Pruneri G et al (2003) Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 27:513–518

    Article  PubMed  Google Scholar 

  • Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609

    Article  PubMed  Google Scholar 

  • Martel P, Capdet J, Méry E et al (2008) Critical study of our initial experience of 993 sentinel node biopsies for breast surgery. (In French) Bull Cancer 95:763–772

    PubMed  Google Scholar 

  • Martin RC II, Chagpar A, Scoggins CR et al (2005) Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 241:1005–1015

    Article  PubMed  Google Scholar 

  • McMasters KM, Wong SL, Chao C et al (2001) Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 234:292–300

    Article  PubMed  CAS  Google Scholar 

  • McMasters KM, Chao C, Wong SL et al (2002) Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 95:15–20

    Article  PubMed  Google Scholar 

  • Menes TS, Tartter PI, Mizrachi H et al (2005) Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases. J Am Coll Surg 200:323–327

    Article  PubMed  Google Scholar 

  • Meyer JE, Smith DN, Lester SC et al (1999) Large-core needle biopsy of nonpalpable breast lesions. JAMA 281:1638–1641

    Article  PubMed  CAS  Google Scholar 

  • Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A (2002) Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 28:623–626

    Article  PubMed  CAS  Google Scholar 

  • Montagna E, Viale G, Rotmensz N et al (2009) Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat 118:385–394

    Article  PubMed  CAS  Google Scholar 

  • Moore KH, Sweeney KJ, Wilson ME et al (2007) Outcomes for women with ductal carcinoma-in-situ and a positive sentinek node: a multi-instituional audit. Ann Surg Oncol 14:2911–2917

    Article  PubMed  Google Scholar 

  • Moran CJ, Kell MR, Kerin MJ (2005) The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur J Surg Oncol 31:1105–1111

    Article  PubMed  CAS  Google Scholar 

  • Nagi C, Bleiweiss I, Jaffer S (2005) Epithelial displacement in breast lesions: a papillary phenomenon. Arch Pathol Lab Med 129:1465–1469

    PubMed  Google Scholar 

  • Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924

    Article  PubMed  CAS  Google Scholar 

  • Nos C, Harding-MacKean C, Fréneaux P et al (2003) Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 90:1354–1360

    Article  PubMed  CAS  Google Scholar 

  • Ozmen V, Muslumanoglu M, Cabioglu N et al (2002) Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 76:237–244

    Article  PubMed  CAS  Google Scholar 

  • Ozmen V, Karanlik H, Cabioglu N et al (2006) Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 95:1–6

    Article  PubMed  CAS  Google Scholar 

  • Pal A, Provenzano E, Duffy SW et al (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309

    Article  PubMed  CAS  Google Scholar 

  • Pálka I, Kelemen G, Ormándi K et al (2008) Tumor characteristics in screen-detected and symptomatic breast cancers. Pathol Oncol Res 14:161–167

    Article  PubMed  Google Scholar 

  • Park J, Fey JV, Naik AM et al (2007) A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245:462–468

    Article  PubMed  Google Scholar 

  • Pendas S, Dauway E, Giuliano R et al (2000) Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7:15–20

    Article  PubMed  CAS  Google Scholar 

  • Ponzone R, Maggiorotto F, Mariani L et al (2007) Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg 193:686–692

    Article  PubMed  Google Scholar 

  • Querzoli P, Pedriali M, Rinaldi R et al (2006) Axillary lymph node nanometastases are prognostic factors for disease free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 12:6696–6701

    Article  PubMed  CAS  Google Scholar 

  • Rakha EA, El-Sayed ME, Green AR et al (2007) Prognostic markers in triple-negative breast cancer. Cancer 109:25–32

    Article  PubMed  CAS  Google Scholar 

  • Rakha E, Reis-Filho JS (2009) Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med 133:860–868

    PubMed  Google Scholar 

  • Recht A, Houlihan MJ (1995) Axillary lymph nodes and breast cancer: a review. Cancer 76:1491–1512

    Article  PubMed  CAS  Google Scholar 

  • Rivers AK, Griffith KA, Hunt KK et al (2006) Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 13:36–44

    Article  PubMed  Google Scholar 

  • Sakr R, Bezu C, Raoust I et al (2008) The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes. Int J Clin Pract 62:1730–1735

    Article  PubMed  CAS  Google Scholar 

  • Sapino A, Frigerio A, Peterse JL et al (2000) Mammographically detected in situ lobular carcinoma of the breast. Virchows Arch 436:421–430

    Article  PubMed  CAS  Google Scholar 

  • Sapino A, Cassoni P, Zanon E et al (2003) Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 88:702–706

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Tamaki K, Takeuchi H et al (2001) Management of the axilla in breast cancer: a comparative study between sentinel lymph node biopsy and four-node sampling procedure. Jpn J Clin Oncol 31:318–321

    Article  PubMed  CAS  Google Scholar 

  • Sauer T, Garred O, Lømo J et al (2006) Assessing invasion criteria in fine needle aspirates from breast carcinoma diagnosed as DICS or invasive carcinoma: can we identify an invasive component in addition to DCIS? Acta Cytol 50:263–270

    Article  PubMed  Google Scholar 

  • Schrenk P, Rieger R, Shamiyeh A et al (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614

    Article  PubMed  CAS  Google Scholar 

  • Schrenk P, Konstantiniuk P, Wölfl S et al (2005) Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 92:707–713

    Article  PubMed  CAS  Google Scholar 

  • Schwartz GF, Solin LJ, Olivotto IA et al (2000) Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999. Cancer 88:946–954

    Article  PubMed  CAS  Google Scholar 

  • Shetty MR, Reiman HM Jr (1997) Re: Cserni G. Is small tumour size alone enough for omitting axillary clearance? Eur J Surg Oncol 23:466–467

    Article  Google Scholar 

  • Silverstein MJ, Gierson ED, Colburn WJ et al (1991) Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet 172:211–214

    PubMed  CAS  Google Scholar 

  • Sobin LH, Wittekind C (eds) (2002) UICC TNM classification of malignant tumours, 6th edn. Wiley, New York

    Google Scholar 

  • Sobin L, Gospodarowicz M, Wittekind Ch (eds) (2009) UICC TNM classification of malignant tumours, 7th edn. Wiley, New York

    Google Scholar 

  • Soerjomataram I, Louwman MW, Ribot JG et al (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107:309–330

    Article  PubMed  CAS  Google Scholar 

  • Specht MC, Fey JV, Borgen PI et al (2005) Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 200:10–14

    Article  PubMed  Google Scholar 

  • Sukumvanich P, Bentrem DJ, Cody HS III et al (2007) The role of sentinel lymph node biopsy in Paget’s disease of the breast. Ann Surg Oncol 14:1020–1023

    Article  PubMed  CAS  Google Scholar 

  • Tabar L, Tot T, Dean PB (2007) Breast cancer. Early detection with mammography. Casting type calcifications: sign of a subtype with deceptive features. Thieme, Suttgart

    Google Scholar 

  • Tavassoli FA, Devilee P (eds) (2003) World Health Organization: pathology and genetics. tumours of the breast and female genital organs. IARC Press, Lyon

    Google Scholar 

  • Tew K, Irwig L, Matthews A et al (2005) Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92:1068–1080

    Article  PubMed  CAS  Google Scholar 

  • Todd JH, Dowle C, Williams MR et al (1987) Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56:489–492

    Article  PubMed  CAS  Google Scholar 

  • Tot T (2007) Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Cancer 110:2551–2560

    Article  PubMed  Google Scholar 

  • Tot T (2009) Metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent. Hum Pathol 40:199–205

    Article  PubMed  Google Scholar 

  • Tot T, Tabár L, Dean P (2002). Practical breast pathology. Thieme, Stuttgart

    Google Scholar 

  • Tot T, Pekár Gy, Hofmayer S et al (2009) The distribution of lesions in 1–14-mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch 455:109–115

    Article  PubMed  CAS  Google Scholar 

  • Trentini F, Saint-Aubert B, Quenet F et al (2007) Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases? (In French) Bull Cancer 94:700–704

    PubMed  Google Scholar 

  • Trisal V, Qian D, Wagman LD (2004) Axillary recurrence in DCIS: is axillary lymphadenectomy warranted? Am Surg 70:876–880

    PubMed  Google Scholar 

  • Tsujimoto M, Nakabayashi K, Yoshidome K et al (2007) One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 13:4807–4816

    Article  PubMed  CAS  Google Scholar 

  • Turner RR, Chu KU, Qi K et al (2000) Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574–581

    Article  PubMed  CAS  Google Scholar 

  • van Deurzen CHM, Hobbelink MGG, van Hillegersberg R et al (2007a) Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ. A review. Eur J Cancer 43:993–1001

    Article  Google Scholar 

  • van Deurzen CH, van Hillegersberg R, Hobbelink MG et al (2007b) Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol 29(6):497–505

    Google Scholar 

  • van Deurzen CH, Borgstein PJ, van Diest PJ (2008a) In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol 61:1314–1316

    Article  Google Scholar 

  • van Deurzen CH, de Boer M et al (2008b) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100:1574–1580

    Article  Google Scholar 

  • van Deurzen CH, Bult P, de Boer M et al (2009) Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement? Am J Surg Pathol 33:106–110

    Article  PubMed  Google Scholar 

  • van Iterson V, Leidenius M, Krogerus L et al (2003) Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 82:39–45

    Article  PubMed  Google Scholar 

  • van Wely BJ, Smidt ML, de Kievit IM et al (2008) False-negative sentinel lymph node biopsy. Br J Surg 95:1352–1355

    Article  PubMed  Google Scholar 

  • Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151

    Article  Google Scholar 

  • Veronesi P, Intra M, Vento AR et al (2005) Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 14:520–522

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, De Cicco C, Galimberti VE et al (2007) A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 18:473–478

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, Galimberti V, Paganelli G et al (2009) Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 45:1381–1388

    Article  PubMed  Google Scholar 

  • Verschraegen C, Vinh-Hung V, Cserni G et al (2005) Modeling the effect of tumor size in early breast cancer. Ann Surg 241:309–318

    Article  PubMed  Google Scholar 

  • Viale G, Zurrida S, Maiorano E et al (2005a) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500

    Article  Google Scholar 

  • Viale G, Maiorano E, Pruneri G et al (2005b) Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241:319–325

    Article  Google Scholar 

  • Viale G, Mastropasqua MG, Maiorano E et al (2006) Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch 448:241–247

    Article  PubMed  Google Scholar 

  • Vinh-Hung V, Burzykowski T, Cserni G et al (2003) Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol 22:697–704

    PubMed  Google Scholar 

  • Vinh-Hung V, Verschraegen C, Promish DI et al (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6:R680–R688

    Article  PubMed  Google Scholar 

  • Wada N, Imoto S, Hasebe T et al (2004) Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol 34:113–117

    Article  PubMed  Google Scholar 

  • Wada N, Imoto S, Yamauchi C et al (2006) Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol 32:29–33

    Article  PubMed  CAS  Google Scholar 

  • Wilkie C, White L, Dupont E et al (2005) An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190:563–566

    Article  PubMed  Google Scholar 

  • Wishart GC, Greenberg DC, Britton PD et al (2008) Screen-detected vs. symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer 98:1741–1744

    Article  PubMed  CAS  Google Scholar 

  • Woodward WA, Vinh-Hung V, Ueno NT et al (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24:2910–2916

    Article  PubMed  Google Scholar 

  • Yi M, Krishnamurthy S, Kuerer HM et al (2008) Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196:81–87

    Article  PubMed  Google Scholar 

  • Yu JC, Hsu GC, Hsieh CB et al (2005) Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg 29:813–819

    Article  PubMed  Google Scholar 

  • Zavagno G, De Salvo GL, Bozza F et al (2004) Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat 86:171–179

    Article  PubMed  Google Scholar 

  • Zavagno G, Carcoforo P, Marconato R et al (2005) Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 5:28

    Article  PubMed  Google Scholar 

  • Zgajnar J, Frkovic-Grazio S, Besic N et al (2004) Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients—results of a large series. J Surg Oncol 85:82–87

    Article  PubMed  Google Scholar 

  • Zgajnar J, Hocevar M, Podkrajsek M et al (2006) Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients. Breast Cancer Res Treat 97:293–299

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bács-Kiskun County Teaching Hospital, Nyíri út 38, 6000, Kecskemet, Hungary

    Gábor Cserni

Authors
  1. Gábor Cserni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gábor Cserni .

Editor information

Editors and Affiliations

  1. , University of Szeged, Department of Oncotherapy, Korányi fasor 12, Szeged, 6720, Hungary

    Zsuzsanna Kahán

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Cserni, G. (2011). Sentinel Node Biopsy and Nodal Staging. In: Kahán, Z. (eds) Breast Cancer, a Heterogeneous Disease Entity. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0489-3_7

Download citation

Publish with us

Policies and ethics

Search

Navigation